- Home
- MRKR vs AUST Comparison
MRKR vs AUST Comparison
Compare MRKR & AUST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRKR
- AUST
- Stock Information
- Founded
- MRKR N/A
- AUST 2020
- Country
- MRKR United States
- AUST Canada
- Employees
- MRKR N/A
- AUST N/A
- Industry
- MRKR Biotechnology: Pharmaceutical Preparations
- AUST
- Sector
- MRKR Health Care
- AUST
- Exchange
- MRKR Nasdaq
- AUST Nasdaq
- Market Cap
- MRKR 21.9M
- AUST 21.5M
- IPO Year
- MRKR N/A
- AUST 2022
- Fundamental
- Price
- MRKR $1.57
- AUST $1.42
- Analyst Decision
- MRKR Strong Buy
- AUST
- Analyst Count
- MRKR 1
- AUST 0
- Target Price
- MRKR $19.00
- AUST N/A
- AVG Volume (30 Days)
- MRKR 95.6K
- AUST 156.5K
- Earning Date
- MRKR 03-25-2025
- AUST 03-03-2025
- Dividend Yield
- MRKR N/A
- AUST N/A
- EPS Growth
- MRKR N/A
- AUST N/A
- EPS
- MRKR N/A
- AUST N/A
- Revenue
- MRKR $5,395,849.00
- AUST N/A
- Revenue This Year
- MRKR $64.48
- AUST N/A
- Revenue Next Year
- MRKR N/A
- AUST N/A
- P/E Ratio
- MRKR N/A
- AUST N/A
- Revenue Growth
- MRKR 79.04
- AUST N/A
- 52 Week Low
- MRKR $1.48
- AUST $0.79
- 52 Week High
- MRKR $5.99
- AUST $3.19
- Technical
- Relative Strength Index (RSI)
- MRKR 35.08
- AUST 49.76
- Support Level
- MRKR $1.53
- AUST $1.45
- Resistance Level
- MRKR $1.79
- AUST $1.80
- Average True Range (ATR)
- MRKR 0.18
- AUST 0.15
- MACD
- MRKR 0.03
- AUST -0.00
- Stochastic Oscillator
- MRKR 14.52
- AUST 25.49
About MRKR Marker Therapeutics Inc.
Marker Therapeutics Inc is a clinical-stage immuno-oncology company specializing in the development and commercialization of novel T cell-based immunotherapies and innovative peptide-based vaccines for the treatment of hematological malignancies and solid tumor indications. The company develops product candidates from its MultiTAA T cell technology, which is based on the selective expansion of non-engineered, tumor-specific T cells that recognize tumor-associated antigens, or TAAs, which are tumor targets, and then kill tumor cells expressing those targets. It is also developing peptide-based immunotherapeutic vaccines for the treatment of metastatic solid tumors, as well as PolyStart.
About AUST Austin Gold Corp.
Austin Gold Corp is a gold exploration and development company focused on gold targets and making district-scale gold discoveries in Nevada. Exploration and development of mineral projects is considered the Company's single business segment. Its projects include Kelly Creek in Humboldt County, Lone Mountain and Miller in Elko County, and Fourmile Basin in Nye County.